Skip to main content
. 2021 Oct 20;11:749753. doi: 10.3389/fonc.2021.749753

Table 2.

Study participants’ clinical and demographic features and targeted ncRNA expression levels.

Groups (n)/Characteristics (Unit) Control (25) BC patients (70) Statistics
Age (years)
 ≤50 (n, %) (10, 40%) (39, 55.7%) χ 2 = 1.821, p1 = 0.244
 >50 (n, %) (15, 60%) (31, 44.3%)
BMI (kg/m2)
 <25 (n, %) (20, 80%) (3, 4.3%) N.A
 ≥25 (n, %) (5, 20%) (32, 45.7%)
 N.A (n, %) (0, 0%) (35, 50%)
No. of offspring
 ≤2 (n, %) (17, 68%) (38, 54.3%) χ 2 = 1.42, p1 = 0.233
 >2 (n, %) (8, 32%) (32, 45.7%)
TLC (×103 cell/µl)
 ≤5 (n, %) (20, 80%) (25, 35.7%)
 >5 (n, %) (5, 20%) (45, 64.3%)
Hemoglobin (gm/dl)
 ≤10 (n, %) (1, 4%) (54, 77.1%)
 >10 (n, %) (24, 96%) (16, 22.9%)
Platelet count (×103cell/µl)
 ≤150 (n, %) (2, 8%) (12, 17.2%)
 >150 (n, %) (23, 92%) (58, 82.8%)
Menopause
 Pre (n, %) (17, 68%) (40, 57.1%) χ 2 = 0.904, p1 = 0.341
 Post (n, %) (8, 32%) (30, 42.9%)
Non-Communicable Diseases
 C.V.D. (n, %) (0, 0%) (32, 45.7%) N.A
 D.M. (n, %) (0, 0%) (9, 12.9%)
 None (n, %) (25, 100%) (29, 41.4%)
BC Family History
 No (n, %) (25, 100%) (54, 77.1%)
 Yes (n, %) (0, 0%) (16, 22.9%)
Pt. Surgical History
 No (n, %) (25, 100%) (40, 57.1%) N.A
 Yes (n, %) (0, 0%) (30, 42.9%)
Hormonal Contraceptive Intake
 No (n, %) (25, 100%) (53, 75.7%) N.A
 Yes (n, %) (0, 0%) (17, 24.3%)
CEA (ng/ml) 1.4 (0.99–1.87) 2.39 (0.3–6.6) NS
CA15-3 (U/ml) 6.8 (4.3–17.2) 23.8 (6.3–90.6) p2 < 0.0001*
LINC00511 (Fold change) 0.008 (0.0002–0.97) 2.5 (0.018–21.77) p2 = 0.006*
miR-185-3p (Fold change) 2.14 (0.53–3.04) 0.55 (0.01–2.76) p2 = 0.0001*
miR-301a-3p (Fold change) 0.24 (0.01–1.66) 3.4 (0.14–20.6) p2 = 0.0004*

Data shown as mean ± S.E.M. or median (range) or (n, %), Statistics were computed using GraphPad prism software using Chi square test χ2 (dichotomous parameters), Student’s t-test (parametric data), or Mann–Whitney test (non-parametric data), p1 indicates comparison between number of populations in control and BC groups using Chi-square test, while p2 indicates comparison between mean or median of population in control and BC groups, *Statistical significance p-value < 0.05. [BMI, body mass index; C.V.D., cardiovascular diseases; D.M., diabetes mellitus; TLC, total leucocyte count; N.A., not applicable/not available; NS, non-significant].